Nisa Investment Advisors
UTMD icon

Nisa Investment Advisors’s Utah Medical Products UTMD Stock Holding History

Nisa Investment Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Buy
199
+1
+0.5% +$63 ﹤0.01% 2165
2025
Q4 		$11.1K Buy
198
+166
+519% +$9.62K ﹤0.01% 2169
2025
Q3 		$2.02K Buy
32
+18
+129% +$1.06K ﹤0.01% 2617
2025
Q2 		$801 Buy
+14
New +$761 ﹤0.01% 2779
2025
Q1 		– Sell
-18
Closed -$1.08K – 2981
2024
Q4 		$1.11K Hold
18
– – ﹤0.01% 2659
2024
Q3 		$1.21K Buy
18
+14
+350% +$950 ﹤0.01% 2530
2024
Q2 		$267 Buy
+4
New +$272 ﹤0.01% 2783
2022
Q1 		– Sell
-2,075
Closed -$195K – 2404
2021
Q4 		$195K Buy
2,075
+820
+65% +$83.7K ﹤0.01% 1279
2021
Q3 		$117 Hold
1,255
– – ﹤0.01% 1629
2021
Q2 		$107 Buy
1,255
+1,050
+512% +$90.8K ﹤0.01% 1658
2021
Q1 		$18 Hold
205
– – ﹤0.01% 2143
2020
Q4 		$17K Buy
205
+50
+32% +$4.26K ﹤0.01% 2148
2020
Q3 		$12K Hold
155
– – ﹤0.01% 2090
2020
Q2 		$14K Sell
155
-25
-14% -$2.24K ﹤0.01% 1853
2020
Q1 		$17K Buy
180
+60
+50% +$5.58K ﹤0.01% 1747
2019
Q4 		$13K Sell
120
-1,340
-92% -$136K ﹤0.01% 1788
2019
Q3 		$140K Buy
1,460
+1,340
+1,117% +$125K ﹤0.01% 1406
2019
Q2 		$11K Hold
120
– – ﹤0.01% 1738
2019
Q1 		$11K Hold
120
– – ﹤0.01% 1728
2018
Q4 		$10K Hold
120
– – ﹤0.01% 1661
2018
Q3 		$11K Hold
120
– – ﹤0.01% 1703
2018
Q2 		$13K Sell
120
-30
-20% -$3.13K ﹤0.01% 1662
2018
Q1 		$15K Hold
150
– – ﹤0.01% 1541
2017
Q4 		$12K Hold
150
– – ﹤0.01% 1702
2017
Q3 		$11K Hold
150
– – ﹤0.01% 1727
2017
Q2 		$11K Buy
+150
New +$9.87K ﹤0.01% 1692

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's UTMD Position: Q1 2026 in Review

Nisa Investment Advisors increased its Utah Medical Products (UTMD) stake by 0.51% in Q1 2026, buying an estimated $63 and bringing the position to 199 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Nisa Investment Advisors first reported a position in UTMD in Q2 2017 and has held it in 26 quarters since. The position peaked at $195K in Q4 2021. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Nisa Investment Advisors held 199 shares of Utah Medical Products worth $12.4K as of Q1 2026.
  • Nisa Investment Advisors bought 1 Utah Medical Products share in Q1 2026, an estimated $63.
  • Utah Medical Products made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2165 holding.
  • Nisa Investment Advisors first reported a position in Utah Medical Products in Q2 2017 and has held it in 26 quarters since.
  • Nisa Investment Advisors's Utah Medical Products position peaked at $195K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.